Indaba Capital Management, L.P. Quant / Systematic

CIK: 0001524362 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $233,708 (51.1% shares, 48.9% debt)

Holdings (9)

— EQUITY COMWLTH 40.0%

Value ($000) $93,530 Shares 4,700,000 Est. Cost $19.61 Unrealized —

— ESPERION THERAPEUTICS INC NE 13.7%

Value ($000) $32,019 Shares 33,750,000 Est. Cost $0.95 Unrealized —

— BANDWIDTH INC 13.4%

Value ($000) $31,407 Shares 40,250,000 Est. Cost $0.62 Unrealized —

ONTF ON24 INC 11.1%

Value ($000) $25,950 Shares 4,240,256 Est. Cost $22.91 Unrealized -73.0%

— XOMETRY INC 7.9%

Value ($000) $18,551 Shares 21,750,000 Est. Cost $0.77 Unrealized —

— ACCELERATE DIAGNOSTICS INC 5.3%

Value ($000) $12,410 Shares 24,083,901 Est. Cost $0.64 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 3.4%

Value ($000) $7,961 Shares 9,000,000 Est. Cost $0.88 Unrealized —

— STANDARD BIOTOOLS INC 3.3%

Value ($000) $7,632 Shares 7,660,000 Est. Cost $1.00 Unrealized —

— SUMMIT HOTEL PPTYS 1.8%

Value ($000) $4,248 Shares 4,500,000 Est. Cost $0.94 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EQUITY COMWLTH	4,700,000	$93,530	40.0%	$19.61	—	COM SH BEN INT	294628102
—	ESPERION THERAPEUTICS INC NE	33,750,000	$32,019	13.7%	$0.95	—	NOTE 4.000%11/1	29664WAB1
—	BANDWIDTH INC	40,250,000	$31,407	13.4%	$0.62	—	NOTE 0.500% 4/0	05988JAD5
ONTF	ON24 INC	4,240,256	$25,950	11.1%	$22.91	-73.0%	COM	68339B104
—	XOMETRY INC	21,750,000	$18,551	7.9%	$0.77	—	NOTE 1.000% 2/0	98423FAB5
—	ACCELERATE DIAGNOSTICS INC	24,083,901	$12,410	5.3%	$0.64	—	NOTE 5.000%12/1	00430HAC6
—	IRONWOOD PHARMACEUTICALS INC	9,000,000	$7,961	3.4%	$0.88	—	NOTE 1.500% 6/1	46333XAH1
—	STANDARD BIOTOOLS INC	7,660,000	$7,632	3.3%	$1.00	—	NOTE 5.250%12/0	34385PAF5
—	SUMMIT HOTEL PPTYS	4,500,000	$4,248	1.8%	$0.94	—	NOTE 1.500% 2/1	866082AA8